manifestări extrahepatice în hepatitele cronice la copil - Gr.T. Popa

34. Iashina TL, Favorov MO, Shakhgil'dian IV, et al. The prevalence of the markers
of viral hepatitis B and delta among the population in regions differing in the level
of morbidity. (In Russian). Vopr Virusol 1992;37:194-6
35. Brasil LM, da Fonseca JC, de Souza RB, et al. Prevalence of hepatitis B virus
markers within household contacts in the State of Amazonas. Rev Soc Bras Med
Trop 2003;36:565-70
36. Duca E., Cercetări epidemiologice, clinice şi de laborator pentru evidenţierea
particularităţilor procesului epidemiologic în hepatita virală B, în Judeţul Iaşi, în
perioada 1991-2006. Teză de doctorat, conducător ştiinţific Prof. dr. A.Ivan,
Universitatea de Medicină şi Farmacie „Gr.T.Popa” Iaşi, 2007
37. Poethko-Muller C, Kuhnert R, Schlaud M. Vaccination coverage and predictors
for vaccination level. Results of the German Health Interview and Examination
Survey for Children and Adolescents (KiGGS). Bundesgesundheitsblatt
Gesundheitsforschung Gesundheitsschutz 2007;50(5-6):851
38. Wasley A, Grytdal S, Gallagher K. Surveillance for acute viral hepatitis--United
States, 2006. MMWR Surveill Summ 2008;57(2):1
39. Haley RW, Fischer RP. Commercial tattooing as a potentially important source of
hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware
of their hepatitis C serologic status. Medicine (Baltimore) 2001;80(2):134
40. Danta M, Brown D, Bhagani S, et al. Recent epidemic of acute hepatitis C virus
in HIV-positive men who have sex with men linked to high-risk sexual
behaviours. Aids 2007;21(8):983
41. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C
virus infection in the United States, 1988 through 1994. NEJM 1999;341(8):556
42. Wedemeyer H, Heidrich B, Manns MP. Hepatitis D virus infection - Not a
vanishing disease in Europe! Hepatology 2007; 45(5):1331-1332
43. Niro GA, Casey JL, Gravinese E, Garrubba M, Conoscitore P, Sagnelli E et al.
Intrafamilial transmission of hepatitis delta virus: molecular evidence. J Hepatol
1999; 30(4):564-569
44. Wedemeyer H., Yurdaydin C. Delta Hepatitis. In: Tillman HL, editor. Handbuch
Hepatitis B: Diagnostik, Verlauf,Therapie. Bremen: Uni-Med, 2007: 96-103
45. Gaeta GB, Stroffolini T, Chiaramonte M, Ascione T, Stornaiuolo G, Lobello S et
al. Chronic hepatitis D: a vanishing Disease? An Italian multicenter study.
Hepatology 2000; 32(4 Pt 1):824-827
46. Wedemeyer H., Yurdaydin C. Delta Hepatitis. In: Tillman HL, editor. Handbuch
Hepatitis B: Diagnostik, Verlauf, Therapie. Bremen: Uni-Med, 2007: 96-103
47. Degertekin H, Yalcin K, Yakut M, Yurdaydin C. Seropositivity for delta hepatitis
in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis.
Liver Int 2008; 28(4):494-498
48. Tsatsralt-Od B, Takahashi M, Nishizawa T, Endo K, Inoue J, Okamoto H. High
prevalence of dual or triple infection of hepatitis B, C, and delta viruses among
patients with chronic liver disease in Mongolia. J Med Virol 2005; 77(4):491-499
49. Zacharakis GH, Koskinas J, Kotsiou S, Papoutselis M, Tzara F, Vafeiadis N, et al.
Natural history of chronic HBV infection: a cohort study with up to 12 years
follow-up in North Greece (part of the Interreg I-II/EC-project). J Med Virol.
2005 Oct;77(2):173-9